Article
Revolutionizing Antifibrinolytic Therapy: Personalized Strategies for Total Hip Arthroplasty Patients Who Have Divergent Fibrinolytic Responses.
The Journal of arthroplasty - 1 Nov 2025
Luo Xuefeng, Liu Jiacheng, Zhang Tao, Su Bao, Huang Wei, Lei Yiting
Abstract excerpt
BACKGROUND: While empirical antifibrinolysis immediately postsurgery effectively reduces postoperative hidden blood loss (HBL), the emerging concept of fibrinolytic phenotypes may challenge this routine practice. This randomized controlled trial investigated the efficacy of using the fibrinolytic marker LY30 to distinguish divergent phenotypes following total hip arthroplasty (THA), thereby enabling personalized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
